Prime Medicine Inc (PRME)
7.04
+0.28
(+4.14%)
USD |
NASDAQ |
May 16, 16:00
7.02
-0.02
(-0.28%)
After-Hours: 20:00
Prime Medicine Free Cash Flow: -200.61M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -200.61M |
| December 31, 2023 | -174.14M |
| September 30, 2023 | -163.96M |
| Date | Value |
|---|---|
| June 30, 2023 | -156.77M |
| March 31, 2023 | -139.00M |
| December 31, 2022 | -147.92M |
Free Cash Flow Range, Past 5 Years
-200.61M
Minimum
Mar 2024
-139.00M
Maximum
Mar 2023
-163.73M
Average
-160.37M
Median
Free Cash Flow Benchmarks
| 10x Genomics Inc | -73.95M |
| Verve Therapeutics Inc | -149.88M |
| Ionis Pharmaceuticals Inc | -345.48M |
| Solid Biosciences Inc | -95.70M |
| Beam Therapeutics Inc | -169.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -67.71M |
| Cash from Investing (Quarterly) | -37.03M |
| Cash from Financing (Quarterly) | 157.33M |
| Free Cash Flow Per Share (Quarterly) | -0.6704 |
| Free Cash Flow to Firm (Quarterly) | -70.03M |
| Free Cash Flow Yield | -30.05% |